FDA Adverse Event Injury Summary report: N

MULTI-LINK RX VISION CORONARY STENT SYSTEM

MDR report key: 1895022 · Received November 5, 2010

Report

Report Number
2024168-2010-02368
Event Type
Injury
Date Received
November 5, 2010
Date of Event
April 27, 2010
Report Date
October 13, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
MAF
PMA / PMN Number
P020047
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PT EFFECT OF RESTENOSIS, AS LISTED IN THE VISION INSTRUCTIONS FOR USE (IFU) IS A KNOWN ADVERSE EVENT ASSOCIATED WITH CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING. THE 3.0 X 23 MM MULTI-LINK RX VISION (PART 1007842-23J, LOT UNK), INDICATED IS BEING FILE UNDER A SEPARATE MFR#.

Description of Event or Problem · 1

IT WAS REPORTED THAT TWO VISION STENTS WERE IMPLANTED IN THE RCA LESION ON (B)(6) 2009. ON (B)(6) 2010, A 3.5 X 28 MM AND A 3.5 X 18 MM XIENCE V STENT WERE IMPLANTED IN THE LESION BECAUSE OF THE RESTENOSIS OF THE VISION STENTS. THE STENOSIS IMPROVED FROM 90% TO 0%. THE VESSEL DIAMETER AND LENGTH IN WHICH XIENCE V STENTS WERE IMPLANTED: 3.5 MM AND 40 MM. NO PT EFFECTS WERE REPORTED. NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MULTI-LINK RX VISION CORONARY STENT SYSTEM MAF ABBOTT VASCULAR-CARDIAC THERAPIES NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization| R MULTI-LINK RX VISION (PART 1007842-23J, LOT UNK)| STENT: 3.0 X 23 MM| GUIDE: CATH: HEARTRAIL 6F IR1.0| VOYAGER NC 3.5 X 15MM| DILATATION CATHETER: TAZUNA 3.0 X 15MM| HIRYU 3.5 X 20MM| GUIDE WIRE: RUNTHOUGH, EXTRA FLOPPY, PT2